loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products of Loxo Oncology Inc listed with Health Canada. Original Data : Health Canada Website

    Client Virtual Booth
    Menu

    Loxo Oncology Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 SELPERCATINIB (2)

    filter

    01 CAPSULE (2)

    filter

    01 40MG (1)

    02 80MG (1)

    filter

    01 RETEVMO (2)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      SELPERCATINIB

      PDF Supplier PDF
      URL Supplier Web Content
      CAPSULE
      40MG
      RETEVMO
      2516918
      Prescription
      Canada
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        SELPERCATINIB

        PDF Supplier PDF
        URL Supplier Web Content
        CAPSULE
        80MG
        RETEVMO
        2516926
        Prescription
        Canada
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Post Enquiry
        POST ENQUIRY